These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 28140325)

  • 41. Targeting gut microbiota as a possible therapy for diabetes.
    He C; Shan Y; Song W
    Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The gut microbiota as a therapeutic target for obesity: a scoping review.
    Santos-Paulo S; Costello SP; Forster SC; Travis SP; Bryant RV
    Nutr Res Rev; 2022 Dec; 35(2):207-220. PubMed ID: 34100344
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modulation of the gut microbiota-adipose tissue-muscle interactions by prebiotics.
    Rodriguez J; Delzenne NM
    J Endocrinol; 2021 Apr; 249(1):R1-R23. PubMed ID: 33502337
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Obesity and gut-microbiota-brain axis: A narrative review.
    Asadi A; Shadab Mehr N; Mohamadi MH; Shokri F; Heidary M; Sadeghifard N; Khoshnood S
    J Clin Lab Anal; 2022 May; 36(5):e24420. PubMed ID: 35421277
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of habitual dietary fibre intake on the responsiveness of the gut microbiota to a prebiotic: protocol for a randomised, double-blind, placebo-controlled, cross-over, single-centre study.
    Healey G; Brough L; Butts C; Murphy R; Whelan K; Coad J
    BMJ Open; 2016 Sep; 6(9):e012504. PubMed ID: 27591024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Gut microbiota and obesity: Pathogenetic relationships and ways to normalize the intestinal microflora].
    Drapkina OM; Korneeva ON
    Ter Arkh; 2016; 88(9):135-142. PubMed ID: 28635818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interplay of Gut Microbiota, Probiotics in Obesity: A Review.
    Pothuraju R; Sharma RK
    Endocr Metab Immune Disord Drug Targets; 2018; 18(3):212-220. PubMed ID: 29384067
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gut microbiota and type 2 diabetes mellitus.
    Muñoz-Garach A; Diaz-Perdigones C; Tinahones FJ
    Endocrinol Nutr; 2016 Dec; 63(10):560-568. PubMed ID: 27633134
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The role of gut microbiota in the pathogenesis of obesity and diabetes].
    Stachowicz N; Kiersztan A
    Postepy Hig Med Dosw (Online); 2013 Apr; 67():288-303. PubMed ID: 23619228
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT).
    Lee P; Yacyshyn BR; Yacyshyn MB
    Diabetes Obes Metab; 2019 Mar; 21(3):479-490. PubMed ID: 30328245
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A High-Fat Diet Increases Gut Microbiota Biodiversity and Energy Expenditure Due to Nutrient Difference.
    Wang B; Kong Q; Li X; Zhao J; Zhang H; Chen W; Wang G
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33092019
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The gut microbiota attenuates muscle wasting by regulating energy metabolism in chemotherapy-induced malnutrition rats.
    Chen H; Xu C; Zhang F; Liu Y; Guo Y; Yao Q
    Cancer Chemother Pharmacol; 2020 Jun; 85(6):1049-1062. PubMed ID: 32415349
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Understanding the role of gut microbes and probiotics in obesity: how far are we?
    Sanz Y; Rastmanesh R; Agostoni C
    Pharmacol Res; 2013 Mar; 69(1):144-55. PubMed ID: 23147032
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Precision Nutrition and the Microbiome Part II: Potential Opportunities and Pathways to Commercialisation.
    Mills S; Lane JA; Smith GJ; Grimaldi KA; Ross RP; Stanton C
    Nutrients; 2019 Jun; 11(7):. PubMed ID: 31252674
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Microbiota and the Gut-Brain Axis in Controlling Food Intake and Energy Homeostasis.
    Romaní-Pérez M; Bullich-Vilarrubias C; López-Almela I; Liébana-García R; Olivares M; Sanz Y
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072450
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early life gut microbiota: Consequences for health and opportunities for prevention.
    Wang S; Cui J; Jiang S; Zheng C; Zhao J; Zhang H; Zhai Q
    Crit Rev Food Sci Nutr; 2024; 64(17):5793-5817. PubMed ID: 36537331
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gut Hormones in Health and Obesity: The Upcoming Role of Short Chain Fatty Acids.
    Alhabeeb H; AlFaiz A; Kutbi E; AlShahrani D; Alsuhail A; AlRajhi S; Alotaibi N; Alotaibi K; AlAmri S; Alghamdi S; AlJohani N
    Nutrients; 2021 Jan; 13(2):. PubMed ID: 33572661
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health.
    Parker A; Fonseca S; Carding SR
    Gut Microbes; 2020; 11(2):135-157. PubMed ID: 31368397
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
    Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
    Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gut microbial characteristics in poor appetite and undernutrition: a cohort of older adults and microbiota transfer in germ-free mice.
    Fluitman KS; Davids M; Olofsson LE; Wijdeveld M; Tremaroli V; Keijser BJF; Visser M; Bäckhed F; Nieuwdorp M; IJzerman RG
    J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2188-2201. PubMed ID: 35698917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.